Clover Biopharmaceuticals, Ltd. (HKG:2197)

Clover Biopharmaceuticals Revenue

In the year 2025, Clover Biopharmaceuticals had annual revenue of 3.51M CNY, down -90.88%. Clover Biopharmaceuticals had revenue of 251.00K in the half year ending December 31, 2025, a decrease of -99.36%.

• Revenue: 3.51M CNY
• Revenue Growth: -90.88%
• P/S Ratio: 665.59
• Revenue / Employee: 13.64K CNY
• Employees: 257
• Market Cap: 2.60B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.51M	-34.91M	-90.88%
Dec 31, 2024	38.42M	-836.00K	-2.13%
Dec 31, 2023	39.26M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error